We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Current and Emerging Drugs for the Treatment of Inflammatory Bowel Disease

News   May 25, 2011

 
Current and Emerging Drugs for the Treatment of Inflammatory Bowel Disease
 
 
Advertisement
 

RELATED ARTICLES

Novel Inhibitor Shown To Combat Drug-Resistant Tumor Cells

News

A team of researchers from Martin Luther University Halle-Wittenberg and the University of Greifswald has developed a new inhibitor of multi-drug resistant protein 4 (MRP4). When the inhibitor was tested on drug-resistant cancer cell lines, the cancer cells began to respond to chemotherapy.

READ MORE

Tailoring Botox Proteases To Target New Proteins

News

A team of researchers has demonstrated that it is possible to rapidly evolve botulinum toxin in the laboratory to target a variety of different proteins.

READ MORE

New Method for Asymmetric N,N-Acetal Synthesis Set To Aid Drug Development

News

A lot of medicines and other bioactive drugs are based on chemical structures called "enantiomers", among them are chiral N,N-acetals. A new study presents the first highly stereoselective formation of chiral N,N-acetals from α-ketoesters using an original catalyst.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE